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We report the Laser Induced Forward Transfer (LIFT) of antibodies from a liquid
donor film onto paper receivers for application as point-of-care diagnostic sensors.
To minimise the loss of functionality of the active biomolecules during transfer, a
dynamic release layer was employed to shield the biomaterial from direct
exposure to the pulsed laser source. Cellulose paper was chosen as the ideal
receiver because of its inherent bio-compatibility, liquid transport properties, wide
availability and low cost, all of which make it an efficient and suitable platform
for point-of-care diagnostic sensors. Both enzyme-tagged and untagged IgG
antibodies were LIFT-printed and their functionality was confirmed via a
colorimetric enzyme-linked immunosorbent assay. Localisation of the printed
antibodies was exhibited, which can allow the creation of complex 2-d patterns
such as QR codes or letters for use in a final working device. Finally, a calibration
curve was determined that related the intensity of the colour obtained to the
concentration of active antibodies to enable quantitative assessment of the device
performance. The motivation for this work was to implement a laser-based
procedure for manufacturing low-cost, point-of-care diagnostic devices on paper.
VC 2014 AIP Publishing LLC. [http://dx.doi.org/10.1063/1.4878696]
I. INTRODUCTION
The development and applications of point-of-care diagnostic devices have been growing
significantly over the last few years for use away from the medical and laboratory infrastructure
which is present in a hospital or doctor’s surgery.1,2 These tests should require very small sam-
ple volumes (<1ml) with little or no preparation, and can provide the result much faster than
routine lab tests. Additionally, such tests should be implemented and interpreted without any
special training or equipment, and can be administered in the home environment, while they
are most importantly low-cost to buy and transport. The transfer and immobilisation of biomo-
lecules on the device during its fabrication has a critical role and is usually achieved by spot-
ting, injection, or photolithography.3,4 The ultimate goal of this study, however, is the
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development of paper-based diagnostic devices, using a laser-based printing procedure called
Laser Induced Forward Transfer (LIFT) as an alternative for the deposition of biomolecules,
which enables printing of reagent volumes as low as a few nanolitres.
LIFT is a laser-based direct-write additive technique used for depositing materials from a
thin donor film onto a receiver, as shown schematically in Figure 1. The donor film is pre-
deposited on a carrier that is transparent to the incident laser light, and photons from the laser
source provide the driving force that transfers a small volume of the donor material onto the
accepting receiver. The LIFT technique was first proposed by Bohandy et al.5 for deposition of
Cu films using an ArF excimer laser, but since then it has been employed for printing a wide
range of materials, including metals, oxides, polymers, ceramics, organics as well as biomole-
cules, for applications as diverse as embedded electronic circuits, integrated photonic devices,
and tissue engineering.6–10 For printing of biological donor materials, the transfer of cells,11–16
fungi,17 proteins,18–21 bacteria,22 and DNA23–26 has already been reported in the literature,
where one of the most fundamental requirements is to demonstrate the printing of viable and
functional samples, although previous work was not targeted towards point-of-care paper-based
diagnostics. This laser-based approach to printing of biomolecules has several inherent advan-
tages; operation in a standard ambient environment allows printing of a wide range of materials
with the further possibility of transferring multi-layered 3D structures composed of different
materials. In addition, a further flexibility presents itself in the form of precise control of the
size and shape of the printed pixels which is possible by controlling the parameters of the inci-
dent laser light such as wavelength, pulse duration, energy density, and spatial beam profile.6,27
Pixelated test patterns in the form of barcodes and QR codes represent an immediate advantage
over isolated spot-printing when the outcome of the test results should remain secure or be oth-
erwise encoded until interpreted by trained staff. We have chosen for this work a modified
LIFT procedure, referred to as Dynamic Release Layer (DRL-LIFT),28 which employs the use
of a sacrificial layer that absorbs the energy of the incident laser pulses and therefore protects
the biomolecules from radiation. Materials commonly used as DRLs include gold,29 silver,17
titanium,22,25 or more cost-effective polymers, such as triazene.12,28,30,31
The use of paper as a platform to build low-cost sensing devices was proposed by
Whitesides et al. in 2007, and since then its use for developing such sensing devices is well-
documented.1,32 Paper is readily available in a range of different grades, thicknesses and forms,
and has a wide variety of properties such as wettability, porosity, and capability to wick liquid
solutions.32 Additional features that make paper very attractive for point-of-care sensors are
that liquid flow can occur without the need for external pumps, and the flow rate can also be
adjusted by suitable pre-treatment processes.33 Finally, it is easily and inexpensively stored and
transported, is biocompatible and can be incinerated for easy and safe disposal after use. With
all these intrinsic benefits as well as fulfilling the low-cost requirement, we have chosen paper
as the receiver medium onto which the sensor would be fabricated. The present work demon-
strates the use of one of the most routinely employed papers—cellulose-based filter paper—as
the receiver for our LIFT-printing studies.
In this paper, we present a DRL-LIFT-printing approach that uses an Au DRL to transfer a
liquid donor that contains either enzyme-tagged or untagged antibodies. The functionality of the
FIG. 1. Schematic of the LIFT setup for liquid donor transfer.
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antibodies post-transfer was validated by an indirect colorimetric Enzyme Linked
Immunosorbent Assay (ELISA),34 thereby demonstrating a LIFT-printed paper-based ELISA.
ELISA is a commonly used method for biochemical analysis that provides high sensitivity and
selectivity through enzymatic signal amplification. Paper-based ELISA tests35 allow for quick
and reliable diagnostics with minimal reagent volumes and in conjunction with the patterning
ability of LIFT should make possible the fabrication of personalised biosensors, and this con-
cept is further described in a later section. Our results demonstrate the first steps towards our
final goal of laser-printed, low-cost, point-of-care paper-based diagnostic sensors.
II. EXPERIMENTAL METHODS
A. Materials and methods
The untagged antibodies used in the present experiments were purified mouse IgG2a (BD
Biosciences, UK, 557353). The enzyme-conjugated antibodies were goat anti-mouse IgG
(HþL) (Life Technologies, UK, G21040) tagged with horseradish peroxidase (HRP), an
enzyme which has the ability to catalyze the conversion of the chromogenic substrate,
3,30,5,50-Tetramethylbenzidine (TMB) (Sigma-Aldrich, T0440), which when oxidised yields a
characteristic colour change (to blue) that is easily detectable visually by the human eye or a
camera. The blocking solution was >98% lyophilised bovine serum albumin (BSA)
(Sigma-Aldrich, A3059) in a 2% concentration of Phosphate Buffered Saline (PBS) (PAA
Laboratories, UK, H15-001). The glycerol used for the donor film was >99% pure (Fisher
Scientific, G/0600/08) and Tween20 (Sigma-Aldrich, P1379) was used as a surfactant in the
“washing” and “blocking” stages in a 0.05% concentration in PBS.
B. Experimental setup
The schematic in Fig. 1 shows the setup used for these trial LIFT-printing experiments.
The laser used was a KrF excimer operating at 248 nm with a repetition rate of 1Hz, pulse du-
ration of 10 ns, and delivering a maximum energy of 400 mJ per pulse. This laser was cho-
sen due to its immediate availability and to demonstrate the technique as a proof-of-principle,
while other less expensive lasers can be used. An aperture was used to select a smaller central
area of the beam, which had an acceptable spatial uniformity, and this was subsequently imaged
via a lens with a focal length of 30 cm onto the interface of the fused silica carrier and the do-
nor providing a laser spot area of 700 lm 700 lm, large enough to produce a transfer-
printed pixel that could be observed without the aid of an imaging device. The energy density
required for printing should exceed the LIFT threshold, which was experimentally determined
to be 200 mJ/cm2. Two standard manual xyz-axes translational stages were used for position-
ing the donor and the receiver, which were separately controllable, allowing for LIFT-printing
from different areas of the donor onto selected areas of the receiver. The vertical axis of both
translation stages was adjusted such that the plane of the donor was set at the image plane of
the aperture and the receiver was set at a separation of 100 lm from the donor surface.
C. Preparation of the donor
A 1mm thick fused silica carrier, pre-cleaned using a standard solvent cleaning procedure,
was then coated with a 25 nm Au film using e-beam evaporation, and this acted as the DRL. In
order to improve the hydrophilicity, and hence adhesion, the Au DRL film was treated with an
O2 plasma for 20 s. A liquid donor film, consisting of a glycerol–PBS solution (80% v/v) was
then formed on the carrier by containing it in a square well using tape (Fig. 2) or by using a
wire coater (Gardco, US). In the first case, the addition of the donor solution near one edge of
the predefined well was followed by spreading across the well by a glass slide to remove the
excess liquid donor and thereby form a film. Alternatively, about 200ll of the solution was
pipetted on the carrier and spread with the wire coater whilst removing any excess liquid, lead-
ing to the formation of a 65lm thick film. The uniformity and reproducibility of the film’s
thickness using the wire coater method proved to be better, and hence was the selected
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approach. The antibodies, either the secondary (enzyme-tagged anti-mouse IgG) or the primary
(untagged mouse IgG), were incorporated in this film in concentrations ranging from ng/ml to
lg/ml, prior to the forming of the film on the carrier.
The receiver was Whatman grade 1 filter paper. Nitrocellulose paper, which exhibits much
higher hydrophobicity and results in localisation and immobilisation of antibodies and other
biomolecules, is an alternative material in many point-of-care sensors.32 Our results show that
similar attributes are observed for LIFT-printing on simple cellulose paper, where antibodies
also exhibited high localisation within the LIFT-printed areas. Indeed it was observed that the
glycerol was absorbed in the cellulose paper faster and with greater efficiency than in the nitro-
cellulose paper, for which the droplets were not completely absorbed within the volume of the
paper, but are adsorbed on its surface with excess liquid evaporating over time as the paper is
left to dry under ambient lab conditions. Since we could implement the ELISA on a cellulose
paper, the more expensive nitrocellulose was not trialled as a receiver in our experiments.
III. RESULTS AND DISCUSSION
Two sets of LIFT-printing experiments are presented here. The first included the direct
LIFT-printing of enzyme-tagged antibodies on paper. In order to show the functionality of the
antibody-HRP enzyme conjugate post printing, it is necessary that a change in colour (from
white in the absence of HRP to blue in the presence of HRP) is observed at the LIFT-printed
positions on paper as a consequence of the presence of the enzyme that induces the colour
change on interaction with the chromogenic substrate. This would thus confirm the retention of
the biological and chemical properties of the printed antibodies after LIFT-printing. The second
set of experiments involved LIFT-printing of untagged antibodies on paper and the subsequent
detection of these antibodies via an indirect ELISA test, which provides proof of their immuno-
logical functionality and stability following the LIFT-printing process.
Different concentrations, ranging from 50 ng/ml to 500 ng/ml, of the HRP-conjugated anti-
bodies were incorporated into the donor films and pixels were LIFT-printed onto cellulose pa-
per. The volume of each deposited pixel is approximately 35 nl, as calculated by the volume of
the donor film that is removed from the carrier. The LIFT-printed pixels were left to dry for
10min, and the chromogenic substrate TMB was added in order to induce a colour change,
that would confirm that the antibodies retain their functionality post-LIFT-printing. These initial
tests were designed to demonstrate the feasibility of LIFT-printing antibodies and to determine
the lowest concentration that can provide a sufficiently intense colour change that is detectable
with the human eye or a simple mobile phone camera, the only two options considered to be
convenient and beneficial for point-of-care delivery. Spectrophotometry or other more sophisti-
cated and instrument-intensive detection schemes were therefore not used for the functionality
testing procedures as our future aim is to develop a device that operates outside normal medical
FIG. 2. Image showing a glycerol donor film on a fused silica carrier after LIFT-printing of specific pixels. The donor film
is transparent and spread across the whole area of the carrier, while being confined by the surrounding tape-window.
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facilities such as hospitals and furthermore can be read by untrained non-medical personnel/
individuals. It was observed that a concentration of the HRP-conjugated antibodies, lower than
50 ng/ml in PBS represented the threshold at which detection could still be achieved.
Concentrations of antibodies lower than this did not induce a colour change intense enough to
be observable.
The colour intensities of the LIFT-printed pixels were quantified by recording the digital
images with a simple 1.3 megapixel USB camera under ambient laboratory lighting conditions,
followed by analysis of the images using a customised MATLAB program. This program uses
a 256-bit colour scale where black corresponds to a colour intensity of 255 and white to a col-
our intensity of zero. Each image is also represented by three values which correspond to red,
green, and blue colour components in the image. As seen in Fig. 3, the colour intensities of the
LIFT-printed pixels of HRP-conjugated IgG were measured and plotted to create a calibration
curve for known concentrations. The same concentrations of the HRP-conjugated antibodies
were pipetted on the paper receiver, and their images were captured and analysed to create the
calibration curve of the pipetted IgG and identify any loss of antibodies during the LIFT pro-
cess. The background colour of the paper receiver was deducted from the colour intensity of
the LIFT-printed pixels, to improve the signal-to-noise ratio. For a commercial application,
however, a standard colour-map printed adjacent to the test can be used to implement the
subtract-and-compare measurement. Results indicated that the colour intensity of the LIFT-
printed antibodies was reduced by between 2%–4% (when normalised to the full scale of
0–100) compared to the colour intensity of the antibodies which have just been pipetted. This
decrease of the colour intensity can likely be attributed to the denaturing of antibodies during
transfer due to the heating induced by the laser irradiation. Similar decrease in the functionality
of the LIFT-printed biomaterial has been reported in literature, however, these reports describe
a reduction in the viability of LIFT-printed cells, and this was found to be dependent on the
laser fluence.15
A. LIFT-printing in patterns and barcodes
One of the important properties of direct-write laser processing is that it allows for precise
control of the size and shape of both individual printed pixels, as well as the resultant multiple-
pixel patterns that can be printed, which can be varied on an individual basis for specific tests
FIG. 3. Plot of the colour intensity of different concentrations of LIFT-printed HRP-conjugated IgG and of pipetted HRP-
conjugated IgG along with their linear interpolation curves.
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on targeted recipients. Figs. 4(a) and 4(b) show the results for a simplistic LIFT-printed trial
barcode, which further establishes the flexibility inherent to such a laser-based direct write pro-
cedure. The bar code patterns were revealed by addition of the chromogenic substrate TMB
onto the paper after LIFT-printing of the enzyme-tagged antibody to form the desired pattern.
Printing the biomolecules in a shape of a real full-size barcode or QR code would allow addi-
tional information to be added to the test, such as patient-specific details, extra controls such as
test duplication, or encoding of the result where a positive diagnosis might otherwise produce
unintentional patient anxiety (such as in cancer disease monitoring). In practice, for actual
implementation of such tests, barcodes can also identify a specific patient, so that by scanning
and sending the test results with a mobile phone camera to the intended recipient, the health-
care professionals can rapidly be alerted of the patient’s condition. Thus, in the case of a virus
infection, information about their geographical location (via the GPS feature inherent to modern
smartphone devices) would enable rapid vectorial mapping of the spread of the virus. For sim-
ple tests where secrecy or patient confidentiality was not an issue, word patterns36 such as
“yes/no” would facilitate immediate read-out by the patient or person taking the test. Figs. 4(c)
and 4(d) show such LIFT-printed “yes/no” patterns that have been produced by addition of the
chromogenic substrate TMB onto the paper after LIFT-printing the enzyme-tagged secondary
antibody to form the desired word patterns.
B. LIFT-printed paper-based enzyme linked immunosorbent assay
The second set of experiments involved the LIFT-printing of untagged antibodies from a
glycerol donor film onto cellulose paper receivers, and the subsequent validation of their chemi-
cal and biological functionality through an ELISA. An ELISA is a form of analytic biochemical
assay that uses enzymes to detect the presence of an antigen, such as a virus or an antibody,
and is mainly used as a diagnostic tool in medicine and plant pathology, as well as a quality
control in food and environmental industries. Depending on the type of ELISA (indirect, sand-
wich or competitive) that is being implemented, LIFT-printing of at least one type of antibody
specific to the antigen is required. Typically, an ELISA is conducted in a polystyrene multi-
well plate, which in this report was replaced by plain cellulose paper. Eventually, the target
antigen will be in the biological sample to be tested, and the bioassay components will be
FIG. 4. LIFT-printed pixels of HRP-conjugated anti-mouse IgG in the form of a QR code, (a) before the detection with the
chromogenic substrate TMB and after developing with TMB in the form of (b) a 2-d trial barcode QR code, shown as a
black/white pattern in the inset, (c) “yes” and (d) “no.”
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LIFT-printed. However, in the development phase, the target, a mouse IgG, is first bound or
immobilised on the paper surface via the LIFT-printing step. A non-reacting protein (BSA) is
then added onto the paper to block any areas of the paper that the target IgG has not been
immobilised on, and thereby preventing non-specific binding during the subsequent step which
involves the addition of the secondary enzyme-tagged antibody (HRP-conjugated anti-mouse
IgG). This HRP-tagged antibody attaches specifically to the target and on addition of the corre-
sponding chromogenic substrate, TMB, the LIFT-printed pixels turn blue because of oxidation
of the substrate by the enzyme.
The primary untagged antibodies, in concentrations ranging from 0.1 lg/ml to 5 lg/ml,
have been LIFT-printed on the specific areas on the paper and given sufficient time to dry
(10min). Subsequently, the paper was blocked with BSA for 1 h at room temperature, to pre-
vent non-specific binding of the antibodies on the paper during the following steps of the
ELISA test. Although, there are other blocking solutions, BSA was chosen as it is widely avail-
able, are comparatively inexpensive, and commonly used in ELISA tests. We have trialled dif-
ferent blocking concentrations of BSA (1%, 2%, and 5%), and the concentration used was the
one found to be optimal in keeping the background to a minimum. The following step involves
the tagging of the LIFT-printed antibodies with the enzyme-tagged antibodies (HRP-conjugated
anti-mouse IgG). Different concentrations of the secondary tagged antibodies were used to
determine the optimum result, defined as the generation of the highest colour intensity with the
minimum background signal. A concentration of 50 ng/ml was selected as the optimal value.
The paper was immersed in this conjugate solution followed by a washing step to remove any
unbound antibodies and other reagents from the paper surface. Washing was repeated three
times for five minutes each using a washing solution. The final step involved the addition of
the chromogenic substrate TMB which, when combined with the HRP enzymes, produced blue-
coloured pixels, highly localised at the LIFT-printed positions as seen in Fig. 5. It is shown that
even an individual pixel with a volume of the order of nanolitres can provide a sufficient result,
thus minimising the total cost of the test.
The calibration curve for the paper-ELISA using this particular set of antibodies was
obtained as described previously, by capturing images of pixels LIFT-printed with known con-
centrations of antibodies and subsequently measuring the resulting colour intensities (Fig. 6).
The calibration curve would thus allow the determination of unknown concentrations of the tar-
get antibodies in a test-sample. It is clear that the blue colour is highly visible after the ELISA
has been performed. For a future complete system, however, it is desirable to include a calibra-
tion test based on a standard pre-printed blue-coloured control pattern. Current work is designed
to establish the optimum and simplest protocol that could be implemented by the individual
under test.
FIG. 5. Optical microscopy images of LIFT-printed mouse IgG following the ELISA test, forming continuous lines, and
individual pixel arrays.
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IV. CONCLUSIONS
Transfer of untagged and enzyme-linked antibodies on paper receivers was performed using
Laser Induced Forward Transfer with ns laser pulses and the feasibility of LIFT-printing biomole-
cules on paper for the development of a paper-based diagnostic sensor was demonstrated. The
functionality and immunological reactivity of the LIFT-printed antibodies was confirmed by
developing and demonstrating an ELISA protocol and establishing the standard calibration curve
for the LIFT-printed pixels. Additionally, it was shown that the localisation of the LIFT-printed
pixels and immobilisation of the antibodies, which is a pre-requisite for paper-based diagnostic
devices, was maintained throughout the wet-bench process which further justifies our use of the
spatial patterning ability of LIFT. This immobilisation of the antibodies through the LIFT-
printing process on the paper surface, also allowed the use of plain cellulose paper as opposed to
the more expensive nitrocellulose membranes. This will further reduce the final cost and more
importantly allow the fabrication of devices that do not need to be confined by hydrophobic bar-
riers in fluidic channels, but can instead work in free-flow conditions. This work demonstrates
that LIFT is a technique capable of transferring antibodies onto a paper receiver accurately, repro-
ducibly and with minimal loss of biochemical functionality, and that LIFT represents a promising
technology for manufacturing immunologic paper-based point-of-care diagnostic sensors.
The future work of the authors will involve the LIFT-printing of all the necessary reagents
on different sites on the paper and the use of lasers to fabricate fluidic channels. Thus, the
blocking and washing steps will be automated, making the device easier for an untrained indi-
vidual to use.
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